TP53 and gastric cancer: Among TP53 WT gastric cancer patients, the death risk of gastric cancer patients with lymph node detection rate of 60.1%-80% and 80.1%-100% was 5.587 and 3.506 times higher than those with lymph node detection rate of 0–20%, respectively.